Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of the advances in neuromyelitis optica spectrum disorder
Pakeeran Siriratnam, Saif Huda, Helmut Butzkueven, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 12, pp. 103465-103465
Open Access | Times Cited: 18

Showing 18 citing articles:

Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
Paolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3879-3896
Closed Access | Times Cited: 6
Cognitive disorders in patients with neuroimmunological disease
Miguel Restrepo-Martínez, Vaughan Bell, Jesús Ramírez‐Bermúdez
Current Opinion in Psychiatry (2025) Vol. 38, Iss. 2, pp. 126-133
Closed Access
Exploring core symptoms and symptom clusters among patients in neuromyelitis optica spectrum disorder: A network analysis
Hao Liang, Jiehan Chen, Lixin Wang, et al.
International Journal of Nursing Sciences (2025)
Open Access
Is a Benign Disease Course Possible in Untreated AQP4‐IgG NMOSD?
Pakeeran Siriratnam, Chiara Rocchi, Emily Gibbons, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 3
Open Access
Nanomaterials as Novel Matrices to Improve Biomedical Applications of MALDI-TOF/MS
Zhiyi Wang, Yuanting Tang, Ying Zhang, et al.
Talanta (2025), pp. 128092-128092
Closed Access
Microglia/Macrophages in Autoimmune Demyelinating Encephalomyelitis (Multiple Sclerosis/Neuromyelitis Optica)
Ryo Yamasaki
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3585-3585
Open Access
Blood–Brain Barrier Disruption in Neuroimmunological Disease
Fumitaka Shimizu, Masayuki Nakamori
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10625-10625
Open Access | Times Cited: 4
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD
Pakeeran Siriratnam, Saif Huda, Anneke van der Walt, et al.
Neurology (2024) Vol. 103, Iss. 12
Closed Access | Times Cited: 4
Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives
Lorena Lorefice, Rosa Cortese
Multiple Sclerosis and Related Disorders (2024) Vol. 85, pp. 105559-105559
Closed Access | Times Cited: 3
The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study
Xue Ma, Yao Wang, X Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review
Pakeeran Siriratnam, Saif Huda, Helmut Butzkueven, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 2, pp. 103499-103499
Open Access | Times Cited: 6
Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study
Kosuke Matsuzono, Takafumi Mashiko, Reiji Koide, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 1, pp. 275-285
Closed Access | Times Cited: 1
Relapse-Independent Disease Activity in Neuromyelitis Optica Spectrum Disorder: A Systematic Review
Masoud Etemadifar, Seyyed‐Ali Alaei, Tetsuya Akaishi, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 90, pp. 105843-105843
Closed Access | Times Cited: 1
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
Pakeeran Siriratnam, Paul G. Sanfilippo, Anneke van der Walt, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334090
Closed Access | Times Cited: 1
Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets
Yang Zhou, Philippe P. Monnier, Jinzhou Feng, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders
Hongfei Yu, Jin Xu, Yi Fang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5645-5652
Open Access
Neuromyelitis Optica Spectrum Disorder Coexisting with Primary Sjogren's Syndrome and Primary Biliary Cholangitis: A Case Report and literature review
Qi Jia, Xingrong Feng, W. Wang, et al.
Neuroimmunology Reports (2024), pp. 100230-100230
Open Access
Nomogram for the prediction of relapse factors in patients with neuromyelitis optica spectrum disorder during rituximab treatment
Yanning Huang, Lei Wu, Hui Sun, et al.
Neurological Sciences (2024)
Closed Access
Neuromyelitis Optica Spectrum Disorder With Unilateral Retrobulbar Neuritis: A Case Report
Emran Lyutfi, Eva Kasabova, Boyko Matev, et al.
Cureus (2024)
Open Access
Neuromyelitis Optica
Н. Е. Гаврилова, Evelina Kamaeva, Лидия Сопрун, et al.
(2024), pp. 583-586
Closed Access
Page 1

Scroll to top